Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120107) titled 'A Multicenter Study on Meibomian Gland Imaging Radiomics Subtyping and Intervention Strategies Based on Agentic Artificial Intelligence' on March 9.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Fuzhou University Affiliated Provincial Hospital

Condition: Meibomian Gland Dysfunction (MGD) and associated Dry Eye Disease.

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-09

Target Sample Size: Dry Eye Syndrome Observation Group:5000;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=309723

Discla...